scholarly journals Prevalência e resistência bacteriana em infecções urinárias em pacientes atendidos em um laboratório de Fraiburgo/SC/ Prevalence and bacterial resistance in urinary infections in patients at a laboratory of Fraiburgo/SC

2021 ◽  
Vol 7 (12) ◽  
pp. 110331-110342
Author(s):  
Joyce Kelly Busolin Jardim ◽  
Caroline Lehnen ◽  
Thais Mereles Misturini ◽  
Jéssica Favretto ◽  
Jennifer Maria Moschen ◽  
...  
Keyword(s):  
Bacterial Resistance ◽  
Urinary Infections

Uropol for urinary infections

1970 ◽  
Vol 8 (1) ◽  
pp. 3-4
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract ◽  
Bacterial Resistance ◽  
Mixed Infections ◽  
Drug Excretion ◽  
Urinary Infections ◽  
Bright Orange ◽  
Urinary Levels ◽  
Tract Infections ◽  
Lower Urinary

Uropol (Bristol Labs) is a combination of tetracycline phosphate complex, sulphamethizole and phenazopyridine for use in acute and chronic urinary tract infections. The makers claim that it gives therapeutic tissue levels of tetracycline and high urinary levels of sulphonamide, and so reduces the risk of bacterial resistance developing, and that it is useful in the treatment of mixed infections. The addition of phenazopyridine is claimed to provide local analgesia in the lower urinary tract as well as visual assurance of drug excretion by colouring the urine bright orange-red.

Isotopically Labeled Desthiobiotin Azide (isoDTB) Tags Enable Global Profiling of the Bacterial Cysteinome

2019 ◽  
Author(s):  
Patrick R. A. Zanon ◽  
Lisa Lewald ◽  
Stephan M. Hacker
Keyword(s):  
Binding Sites ◽  
Bacterial Resistance ◽  
Mevalonate Pathway ◽  
Rapid Development ◽  
High Reactivity ◽  
Functional Importance ◽  
Essential Proteins ◽  
Covalent Inhibitors ◽  
Druggable Targets ◽  
Covalent Ligands

Rapid development of bacterial resistance has led to an urgent need to find new druggable targets for antibiotics. In this context, residue-specific chemoproteomic approaches enable proteome-wide identification of binding sites for covalent inhibitors. Here, we describe isotopically labeled desthiobiotin azide (isoDTB) tags that are easily synthesized, shorten the chemoproteomic workflow and allow an increased coverage of cysteines in bacterial systems. We quantify 59% of all cysteines in essential proteins in <i>Staphylococcus aureus</i> and discover 88 cysteines with high reactivity, which correlates with functional importance. Furthermore, we identify 268 cysteines that are engaged by covalent ligands. We verify inhibition of HMG-CoA synthase, which will allow addressing the bacterial mevalonate pathway through a new target. Overall, a comprehensive map of the bacterial cysteinome is obtained, which will facilitate the development of antibiotics with novel modes-of-action.

Microarray Technology for the Detection of Antimicrobial Resistance Genes Present in Hospital and Community Acquired Methicillin Resistant S.aureus Strains

2017 ◽  
Vol 68 (11) ◽  
pp. 2546-2550
Author(s):  
Monica Licker ◽  
Andrei Anghel ◽  
Roxana Moldovan ◽  
Elena Hogea ◽  
Delia Muntean ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
Dna Microarray ◽  
Bacterial Resistance ◽  
Meca Gene ◽  
Modern Medicine ◽  
Microarray Technology ◽  
Methicillin Resistant ◽  
Antimicrobial Sensitivity ◽  
Antimicrobial Resistance Genes ◽  
Mrsa Strains

Antimicrobial resistance (AMR) represents a real burden for the modern medicine. One of the most frecvently isolated hospital acquired (HA) pathogens wordlwide, is Methicillin resistant Staphylococcus aureus (MRSA). Recently not only HA, but also community-acquired MRSA (CA-MRSA) infections have been reported. A prospective study was performed between February 2009 and October 2010, with the aim to investigate bacterial resistance of CA-MRSA and HA-MRSA. DNA microarray technology has been used for the detection of 4 AMR genes for the studied MRSA strains. A number of 218 HA- S.aureus strains have been isolated, from which 89 (40. 82%) were MRSA. In the community, 1.553 S.aureus strains were isolated, out of which, 356 (22. 92%) were MRSA. From these, a number of 17 HA and 12 CA �MRSA strains have been analyzed by DNA microarray technology. From 100% phenotypically described HA- MRSA, we identified mecA gene in 10 strains (58. 83%). Other 6 strains (35. 29%) have been erm(A) positive and 4 (23. 53%) - tet(O) positive. 83. 33% (10 strains) from the CA strains had mecA gene, only one (8. 33%) was erm(A) positive and 4 (33. 33%) were erm(C) positive. DNA microarray is a method allowing the concomitant scan of multiple genes and can be done within a few hours. That type of rapid and reliable methods for antimicrobial sensitivity tests are important to start an appropriate therapy.

Insights in Nanoparticle-Bacterium Interactions: New Frontiers to Bypass Bacterial Resistance to Antibiotics

2015 ◽  
Vol 21 (28) ◽  
pp. 4095-4105 ◽  
Author(s):  
Roudayna Diab ◽  
Bahman Khameneh ◽  
Olivier Joubert ◽  
Raphael Duval
Keyword(s):  
Bacterial Resistance ◽  
Resistance To Antibiotics

Nanobiotics: Challenging the anti-microbial perspective - The game changer?

2017 ◽  
Vol 6 (10) ◽  
pp. 5518 ◽  
Author(s):  
Deepak Narang ◽  
Jeevan Singh Tityal ◽  
Amit Jain ◽  
Reena Kulshreshtra ◽  
Fatima Khan
Keyword(s):  
Bacterial Resistance ◽  
Public Health Problem ◽  
Drug Resistant ◽  
European Science Foundation ◽  
Resistance Development ◽  
Bacterial Diseases ◽  
European Science ◽  
Tremendous Impact ◽  
New Strategies ◽  
Game Changer

Antibiotics are the most important medical inventions in human history and are the invaluable weapons to fight against various infectious diseases. Multi drug resistant microorganisms are becoming a serious issue and increasingly public health problem in present day scenario. Antibiotics are becoming less useful due to increasing bacterial resistance. Development of new and more powerful antibiotics leading to drastic pathogens response by developing resistance to the point where the most powerful drugs in our arsenal are no longer effective against them. New strategies for the management of bacterial diseases are urgently needed and nanomaterials can be a very promising approach. Nanobiotics uses nano-sized tools for the successful management bacterial diseases and to gain increased understanding of the complex underlying patho-physiology of disease. (European Science Foundation. Forward Look Nanomedicine: An EMRC Consensus Opinion 2005. Available online: http://www.esf.org (accessed on 15 July 2017). The application of nanotechnologies to medicine, or nanomedicine, which has already demonstrated its tremendous impact on the pharmaceutical and biotechnology industries, is rapidly becoming a major driving force behind ongoing changes in the antimicrobial field. Present review providing important insights on nanobiotics, and their preparation, mechanism of action, as well as perspectives on the opportunities and challenges in nanobiotics.

Sign in / Sign up

Export Citation Format

Share Document